person

José María R. V.

Country
Spain
Department
Dermatology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 26 partner sites.

Specializations

Acne vulgaris

Focused on the treatment of Acne vulgaris with innovative topical formulations.

  • Long‑term safety evaluation
  • Topical gel efficacy
  • Impact on lesion count reduction

Studies incorporate dermatologic imaging and patient‑reported outcome measures.

Female androgenetic alopecia

Investigates therapeutic strategies for female androgenetic alopecia and related hair loss patterns.

  • Oral minoxidil efficacy
  • Combination with topical agents
  • Non‑vellus hair count improvement

Research emphasizes hair regeneration metrics and safety monitoring.

Platysma prominence

Explores interventions for moderate to severe platysma prominence in adult patients.

  • Injectable treatment assessment
  • Single and repeat dose safety
  • Facial contour enhancement outcomes

Clinical work integrates aesthetic evaluation scales and adverse event tracking.

Dermatologic therapeutic innovation

Broadly addresses novel therapeutic approaches within the field of dermatology.

  • Topical delivery technologies
  • Systemic‑local combination regimens
  • Safety profile characterization

Efforts align with regulatory standards and patient‑centered care models.

Skin health and quality of life

Evaluates the relationship between skin disease management and overall patient well‑being.

  • Quality‑of‑life questionnaire integration
  • Longitudinal outcome tracking
  • Holistic patient assessment

Findings support comprehensive care strategies in clinical practice.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.